查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2151884

動物用藥品市場規模、佔有率和趨勢分析報告：按目標動物、產品類型、藥物類型、劑型、給藥途徑、銷售管道、地區和細分市場進行預測（2026-2033 年）

Veterinary Pharmaceuticals Market Size, Share & Trends Analysis Report By Animal, By Product, By Drug Type, By Type, By Route of Administration, By Sales Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

動物用藥品市場概述

全球動物用藥品市場預計到 2025 年將達到 303 億美元，從 2026 年的 333 億美元成長到 2033 年的 686 億美元，2026 年至 2033 年的複合年成長率為 10.9%。

北美市場處於領先地位，到 2025 年將佔銷售額的 36.1%。市場成長的促進因素包括：對預防和治療藥物的需求不斷成長、寵物飼養和獸醫保健支出增加、畜牧業生產擴大以及動物用藥品系統方面的技術進步。

市場集中度和特徵

動物用藥品市場正處於高速成長階段，且成長速度正在加速。該市場的特點包括：對預防性和治療性藥物的需求不斷成長、伴侶動物醫療費用支出增加、畜牧業生產擴張、製劑和給藥系統技術進步、產品組合多元化、監管要求日益嚴格、戰略聯盟、併購活動以及動物醫療保健服務的地域擴張。

這些整合的支柱透過擴大潛在市場規模 (TAM)、開發高階價格區間以及縮短獲利時間，直接推動市場擴張。領導企業透過解決諸如飼主合規摩擦、農業勞動力短缺和嚴格的殘留物法規等關鍵行業挑戰，可以保護其毛利率免受學名藥的侵蝕。尤其重要的是，製藥業正從單純的藥品交易和銷售轉向數據驅動的精準醫療平台，這正推動該行業向高利潤、經常性收入模式轉型，並實現永續的長期企業價值成長。

該市場正經歷持續的創新，這得益於長效製劑、緩釋給藥、物種特異性製劑、聯合治療以及改進劑型等方面的進步。注射劑、口服劑、外用劑和經皮製劑的研發正在提高伴侶動物和生產動物用藥的便利性、效率和給藥方式。此外，製劑技術、藥品生產和分析檢測的進步也為動物用藥品和差異化給藥形式的開發提供了支持。

美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA) 和其他國家獸藥監管機構制定的監管要求對產品的研發、生產、批准、分銷和商業化有重大影響。有關安全性、有效性、殘留限量、生產品質、產品穩定性、標籤和藥物監測的要求會影響研發進度和市場准入。此外，日益嚴格的抗菌藥物使用、動物用藥品殘留和產品生產監管要求也增加了合規成本和成功商業化所需的監管能力。

併購使動物用藥品公司能夠拓展其藥品組合、治療能力、地域覆蓋範圍、生產能力和分銷網路，從而促進市場發展。在動物用藥品和製藥領域，策略性收購能夠幫助企業獲得成熟產品、在開發平臺、生產設施、專業知識和區域市場。此外，動物用藥品經銷商與製藥公司之間的整合能夠增強其綜合商業能力。隨著各公司尋求擴大在伴侶動物和畜牧業製藥市場的業務，併購活動預計將繼續發揮重要作用。

在預防性和治療性動物保健需求日益成長的推動下，製藥商正在拓展產品系列，涵蓋多個藥品類別。這些類別包括抗生素、驅蟲藥、疫苗、止痛藥、抗發炎藥、皮膚病藥物、循環系統藥物和其他治療產品。此外，製藥商也正在開發長效製劑、聯合治療、物種特異性藥物和替代給藥形式，以滿足多樣化的治療需求。產品系列的拓展也提高了對慢性病、特定適應症和弱勢動物群體的覆蓋率，使企業能夠加強其在獸醫院、畜牧場和伴侶動物保健領域的市場地位。

該市場正在北美、歐洲、亞太、拉丁美洲和其他新興市場經歷區域擴張。北美憑藉其完善的獸醫基礎設施、較高的伴侶動物醫療保健支出、先進的製藥能力以及眾多歷史悠​​久的動物用藥品企業，保持著強勁的市場地位。歐洲也擁有成熟的動物用藥品系統，這得益於完善的監管體系、強大的製藥能力和獸醫醫療保健服務。此外，亞太地區的獸藥產業也呈現擴張態勢，這主要得益於畜牧業產量的成長、伴侶動物數量的增加、獸醫基礎設施的完善、獸醫動物用藥品動物用藥品的改善。

目錄

第1章 研究方法和範圍

第2章執行摘要

第3章：動物用藥品市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 科技情勢
  • 價格分析
  • 關稅影響分析
  • 產品平臺分析
  • 以使用者觀點的分析
  • 價值鏈分析
  • 市場分析工具

第4章：動物用藥品市場：依動物種類分類的估算與趨勢分析

  • 動物用藥品市場：依動物種類分類的趨勢分析
  • 動物用藥品市場：依動物種類分類的估算與預測，2021-2033年
  • 生產動物
    • 家禽
    • 豬
    • 牛
    • 綿羊/山羊
    • 其他
  • 伴侶動物
    • 狗
    • 貓
    • 馬
    • 其他

第5章：動物用藥品市場：產品具體估算與趨勢分析

  • 動物用藥品市場：基於產品的趨勢分析
  • 動物用藥品市場：依產品分類的估算與預測，2021-2033年
  • 殺蟲劑
  • 抗感染藥物
  • 消炎（藥）
  • 止痛藥
  • 其他產品

第6章：動物用藥品市場：依藥物類型分類的估算與趨勢分析

  • 動物用藥品市場：依藥物類型分類的趨勢分析
  • 動物用藥品市場：依藥物類型分類的估算與預測，2021-2033年
  • 品牌
  • 學名藥

第7章：動物用藥品市場：按類型分類的估算與趨勢分析

  • 動物用藥品市場：按類型分類的趨勢分析
  • 動物用藥品市場：按類型分類的估算和預測，2021-2033年
  • 處方
  • OTC

第8章：動物用藥品市場：依給藥途徑分類的估算與趨勢分析

  • 動物用藥品市場：依給藥途徑分類的趨勢分析
  • 動物用藥品市場：依給藥途徑分類的估算與預測，2021-2033年
  • 口服
  • 注射藥物
  • 外用
  • 其他給藥途徑

第9章：動物用藥品市場：依銷售管道分類的估算與趨勢分析

  • 動物用藥品市場：依銷售管道分類的趨勢分析
  • 動物用藥品市場：依銷售管道的估算與預測，2021-2033年
  • 向機構銷售
  • 獸藥局和零售店
  • 電子商務
  • 其他頻道

第10章：動物用藥品市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特
    • 阿曼
    • 卡達

第11章 競爭格局

  • 主要公司分類
    • Market Leaders
    • Emerging Players
  • 2025年公司市場分析
  • 2025年企業市場占有率預測分析
  • 公司分類
  • 公司簡介列表
    • ZOETIS INC.
    • Boehringer Ingelheim International Gmbh
    • Merck & Co., Inc.
    • Elanco
    • Dechra
    • Ceva Sante Animale
    • Phibro Animal Health Corporation
    • Virbac
    • Bimeda Corporate
    • Biogenesis Bago
    • Vetoquinol
    • Norbrook Laboratories
Product Code: GVR-4-68041-039-5

Veterinary Pharmaceuticals Market Summary

The global veterinary pharmaceuticals market size was valued at USD 30.3 billion in 2025 and is projected to grow from USD 33.3 billion in 2026 to USD 68.6 billion by 2033, at a CAGR of 10.9% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 36.1% in 2025. Market growth is driven by factors such as increasing demand for preventive and therapeutic pharmaceuticals, rising pet ownership and animal healthcare spending, expansion of livestock production, and technological advancements in veterinary drug formulation and delivery systems.

Market Concentration & Characteristics

The veterinary pharmaceuticals market is in a high-growth stage, with the pace of growth accelerating. The market is characterized by increasing demand for preventive and therapeutic medicines, rising companion animal healthcare spending, expansion of livestock production, technological advancements in drug formulation and delivery systems, portfolio diversification, stringent regulatory requirements, strategic collaborations, M&A activity, and regional expansion of veterinary healthcare services.

These integrated pillars directly catalyze market expansion by broadening total addressable markets, unlocking premium pricing tiers, and shortening time-to-revenue. By resolving critical industry pain points such as owner compliance friction, farm labor shortages, and strict residue regulations, pharmaceutical leaders can protect gross margins against generic erosion. Crucially, transitioning from transactional drug sales to data-enabled, precision-health platforms shifts the sector toward higher-margin, recurring revenue models, driving sustained long-term valuation growth.

The market is witnessing continuous innovation through advances in long-acting formulations, sustained-release drug delivery, species-specific formulations, combination therapies, and improved dosage forms. Development of injectable, oral, topical, and transdermal formulations is improving treatment convenience, dosing efficiency, and administration across companion and production animals. Furthermore, advancements in formulation technologies, pharmaceutical manufacturing, and analytical testing are supporting the development of specialized veterinary medicines and differentiated drug delivery formats.

Regulatory requirements established by agencies such as the FDA, EMA, and other national veterinary pharmaceutical authorities have a high impact on product development, manufacturing, approval, distribution, and commercialization. Requirements related to safety, efficacy, residue limits, manufacturing quality, product stability, labeling, and pharmacovigilance influence development timelines and market entry. Furthermore, tighter requirements governing antimicrobial use, veterinary drug residues, and product manufacturing are increasing compliance costs and raising the regulatory capabilities required for successful commercialization.

Mergers and acquisitions are contributing to market development by enabling animal health companies to expand pharmaceutical portfolios, therapeutic capabilities, geographic presence, manufacturing capacity, and distribution networks. Strategic acquisitions across animal health and pharmaceutical sectors provide access to established products, development pipelines, manufacturing facilities, specialized technologies, and regional markets. Furthermore, consolidation among animal health distributors and pharmaceutical companies is strengthening integrated commercial capabilities. M&A activity is expected to remain relevant as companies seek to broaden their presence across companion animal and livestock pharmaceutical markets.

Increasing demand for preventive and therapeutic animal healthcare is encouraging manufacturers to expand product portfolios across multiple pharmaceutical categories. Products include antibiotics, antiparasitic, vaccines, analgesics, anti-inflammatory drugs, dermatology medicines, cardiovascular drugs, and other therapeutic products. Moreover, manufacturers are expanding into long-acting formulations, combination therapies, species-specific medicines, and alternative delivery formats to address diverse treatment requirements. Portfolio expansion is also supporting greater coverage of chronic conditions, specialty indications, and underserved animal populations, enabling companies to strengthen their presence across veterinary practices, livestock operations, and companion animal healthcare.

The market is experiencing regional expansion across North America, Europe, Asia Pacific, Latin America, and other emerging markets. North America maintains a strong position due to established veterinary healthcare infrastructure, high companion animal healthcare expenditure, advanced pharmaceutical capabilities, and the presence of established animal health companies. Europe also has a developed veterinary pharmaceutical ecosystem supported by established regulatory systems, pharmaceutical capabilities, and animal healthcare services. Furthermore, Asia Pacific is expanding its veterinary pharmaceutical capabilities due to increasing livestock production, rising companion animal ownership, improving veterinary infrastructure, growing animal healthcare expenditure, and increasing availability of veterinary pharmaceutical products.

Global Veterinary Pharmaceuticals Market Report Segmentation

This report forecasts revenue growth at a country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global veterinary pharmaceuticals market report based on animal, product, drug type, type, route of administration, end use, and region:

  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Production Animals
    • Poultry
    • Swine
    • Bovine
    • Ovine & Caprine
    • Others
  • Companion Animals
    • Canine
    • Feline
    • Equine
    • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Parasiticides
  • Anti-infectives
  • Anti-inflammatory
  • Analgesics
  • Other Products
  • Drug Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Branded
  • Generics
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Prescription
  • OTC
  • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Injectable
  • Topical
  • Other Routes
  • Sales Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Institutional Sales
  • Veterinary Pharmacies & Retail
  • E-commerce
  • Other Channels
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Norway
    • Denmark
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Animal
    • 1.2.2. Product
    • 1.2.3. Drug Type
    • 1.2.4. Type
    • 1.2.5. Route of Administration
    • 1.2.6. Sales Channel
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Botton-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Veterinary Pharmaceuticals Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Product Pipeline Analysis
  • 3.7. User Perspective Analysis
  • 3.8. Value Chain Analysis
    • 3.8.1. Supply Trends
    • 3.8.2. Demand Trends
  • 3.9. Market Analysis Tools
    • 3.9.1. Porter's Five Force Analysis
    • 3.9.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary Pharmaceuticals Market: Animal Estimates & Trend Analysis

  • 4.1. Veterinary Pharmaceuticals Market, By Animal: Segment Dashboard
  • 4.2. Veterinary Pharmaceuticals Market, By Animal: Movement Analysis
  • 4.3. Veterinary Pharmaceuticals Market Estimates & Forecasts, By Animal, 2021 - 2033 (USD Million)
  • 4.4. Production Animals
    • 4.4.1. Production Animals Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.4.2. Poultry
      • 4.4.2.1. Poultry Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.4.3. Swine
      • 4.4.3.1. Swine Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.4.4. Bovine
      • 4.4.4.1. Bovine Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.4.5. Ovine & Caprine
      • 4.4.5.1. Ovine & Caprine Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others Market Estimates & Forecasts, 2021 to 2033 (USD Million)
  • 4.5. Companion Animals
    • 4.5.1. Companion Animals Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.5.2. Canine
      • 4.5.2.1. Canine Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.5.3. Feline
      • 4.5.3.1. Feline Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.5.4. Equine
      • 4.5.4.1. Equine Market Estimates & Forecasts, 2021 to 2033 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates & Forecasts, 2021 to 2033 (USD Million)

Chapter 5. Veterinary Pharmaceuticals Market: Product Estimates & Trend Analysis

  • 5.1. Veterinary Pharmaceuticals Market, By Product: Segment Dashboard
  • 5.2. Veterinary Pharmaceuticals Market, By Product: Movement Analysis
  • 5.3. Veterinary Pharmaceuticals Market Estimates & Forecasts, By Product, 2021 - 2033 (USD Million)
  • 5.4. Parasiticides
    • 5.4.1. Parasiticides Market Estimates & Forecasts, 2021 to 2033 (USD Million)
  • 5.5. Anti-infectives
    • 5.5.1. Anti-infectives Market Estimates & Forecasts, 2021 to 2033 (USD Million)
  • 5.6. Anti-inflammatory
    • 5.6.1. Anti-inflammatory Market Estimates & Forecasts, 2021 to 2033 (USD Million)
  • 5.7. Analgesics
    • 5.7.1. Analgesics Market Estimates & Forecasts, 2021 to 2033 (USD Million)
  • 5.8. Other Products
    • 5.8.1. Other Products Market Estimates & Forecasts, 2021 to 2033 (USD Million)

Chapter 6. Veterinary Pharmaceuticals Market: Drug Type Estimates & Trend Analysis

  • 6.1. Veterinary Pharmaceuticals Market, By Drug type: Segment Dashboard
  • 6.2. Veterinary Pharmaceuticals Market, By Drug type: Movement Analysis
  • 6.3. Veterinary Pharmaceuticals Market Estimates & Forecasts, By Drug type, 2021 - 2033 (USD Million)
  • 6.4. Branded
    • 6.4.1. Branded Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Generics
    • 6.5.1. Generics Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary Pharmaceuticals Market: Type Estimates & Trend Analysis

  • 7.1. Veterinary Pharmaceuticals Market, By Type: Segment Dashboard
  • 7.2. Veterinary Pharmaceuticals Market, By Type: Movement Analysis
  • 7.3. Veterinary Pharmaceuticals Market Estimates & Forecasts, By Type, 2021 - 2033 (USD Million)
  • 7.4. Prescription
    • 7.4.1. Prescription Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 7.5. OTC
    • 7.5.1. OTC Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary Pharmaceuticals Market: Route of Administration Estimates & Trend Analysis

  • 8.1. Veterinary Pharmaceuticals Market, By Route of Administration: Segment Dashboard
  • 8.2. Veterinary Pharmaceuticals Market, By Route of Administration: Movement Analysis
  • 8.3. Veterinary Pharmaceuticals Market Estimates & Forecasts, By Route of Administration, 2021 - 2033 (USD Million)
  • 8.4. Oral
    • 8.4.1. Oral Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Injectable
    • 8.5.1. Injectable Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Topical
    • 8.6.1. Topical Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Other Routes
    • 8.7.1. Other Routes Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Veterinary Pharmaceuticals Market: Sales Channel Estimates & Trend Analysis

  • 9.1. Veterinary Pharmaceuticals Market, By Sales Channel: Segment Dashboard
  • 9.2. Veterinary Pharmaceuticals Market, By Sales Channel: Movement Analysis
  • 9.3. Veterinary Pharmaceuticals Market Estimates & Forecasts, By Sales Channel, 2021 - 2033 (USD Million)
  • 9.4. Institutional Sales
    • 9.4.1. Institutional Sales Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Veterinary Pharmacies & Retail
    • 9.5.1. Veterinary Pharmacies & Retail Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 9.6. E-commerce
    • 9.6.1. E-commerce Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 9.7. Other Channels
    • 9.7.1. Other Channels Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Veterinary Pharmaceuticals Market: Regional Estimates & Trend Analysis

  • 10.1. Regional Market Dashboard
  • 10.2. Regional Market Share Analysis, 2025 & 2033
  • 10.3. North America
    • 10.3.1. North America Veterinary Pharmaceuticals Market Estimates & Forecasts, By Country, 2021 - 2033 (USD Million)
    • 10.3.2. U.S.
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Competitive Scenario
      • 10.3.2.3. Regulatory Framework
      • 10.3.2.4. U.S. Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.3.3. Canada
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Competitive Scenario
      • 10.3.3.3. Regulatory Framework
      • 10.3.3.4. Canada Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.3.4. Mexico
      • 10.3.4.1. Key Country Dynamics
      • 10.3.4.2. Competitive Scenario
      • 10.3.4.3. Regulatory Framework
      • 10.3.4.4. Mexico Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 10.4. Europe
    • 10.4.1. Europe Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.4.2. UK
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Competitive Scenario
      • 10.4.2.3. Regulatory Framework
      • 10.4.2.4. UK Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.4.3. Germany
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Competitive Scenario
      • 10.4.3.3. Regulatory Framework
      • 10.4.3.4. Germany Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.4.4. France
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Competitive Scenario
      • 10.4.4.3. Regulatory Framework
      • 10.4.4.4. France Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.4.5. Italy
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Competitive Scenario
      • 10.4.5.3. Regulatory Framework
      • 10.4.5.4. Italy Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.4.6. Spain
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Competitive Scenario
      • 10.4.6.3. Regulatory Framework
      • 10.4.6.4. Spain Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.4.7. Denmark
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Competitive Scenario
      • 10.4.7.3. Regulatory Framework
      • 10.4.7.4. Denmark Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.4.8. Sweden
      • 10.4.8.1. Key Country Dynamics
      • 10.4.8.2. Competitive Scenario
      • 10.4.8.3. Regulatory Framework
      • 10.4.8.4. Sweden Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.4.9. Norway
      • 10.4.9.1. Key Country Dynamics
      • 10.4.9.2. Competitive Scenario
      • 10.4.9.3. Regulatory Framework
      • 10.4.9.4. Norway Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 10.5. Asia Pacific
    • 10.5.1. Asia Pacific Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.5.2. Japan
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Competitive Scenario
      • 10.5.2.3. Regulatory Framework
      • 10.5.2.4. Japan Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.5.3. China
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Competitive Scenario
      • 10.5.3.3. Regulatory Framework
      • 10.5.3.4. China Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.5.4. India
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Competitive Scenario
      • 10.5.4.3. Regulatory Framework
      • 10.5.4.4. India Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.5.5. Australia
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Competitive Scenario
      • 10.5.5.3. Regulatory Framework
      • 10.5.5.4. Australia Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.5.6. South Korea
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Competitive Scenario
      • 10.5.6.3. Regulatory Framework
      • 10.5.6.4. South Korea Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.5.7. Thailand
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Competitive Scenario
      • 10.5.7.3. Regulatory Framework
      • 10.5.7.4. Thailand Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 10.6. Latin America
    • 10.6.1. Latin America Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.6.2. Brazil
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Competitive Scenario
      • 10.6.2.3. Regulatory Framework
      • 10.6.2.4. Brazil Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.6.3. Argentina
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Competitive Scenario
      • 10.6.3.3. Regulatory Framework
      • 10.6.3.4. Argentina Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
  • 10.7. Middle East and Africa
    • 10.7.1. Middle East and Africa Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.7.2. South Africa
      • 10.7.2.1. Key Country Dynamics
      • 10.7.2.2. Competitive Scenario
      • 10.7.2.3. Regulatory Framework
      • 10.7.2.4. South Africa Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.7.3. Saudi Arabia
      • 10.7.3.1. Key Country Dynamics
      • 10.7.3.2. Regulatory Framework
      • 10.7.3.3. Saudi Arabia Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.7.4. UAE
      • 10.7.4.1. Key Country Dynamics
      • 10.7.4.2. Competitive Scenario
      • 10.7.4.3. Regulatory Framework
      • 10.7.4.4. UAE Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.7.5. Kuwait
      • 10.7.5.1. Key Country Dynamics
      • 10.7.5.2. Competitive Scenario
      • 10.7.5.3. Regulatory Framework
      • 10.7.5.4. Kuwait Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.7.6. Oman
      • 10.7.6.1. Key Country Dynamics
      • 10.7.6.2. Competitive Scenario
      • 10.7.6.3. Regulatory Framework
      • 10.7.6.4. Kuwait Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)
    • 10.7.7. Qatar
      • 10.7.7.1. Key Country Dynamics
      • 10.7.7.2. Competitive Scenario
      • 10.7.7.3. Regulatory Framework
      • 10.7.7.4. Kuwait Veterinary Pharmaceuticals Market Estimates & Forecasts, 2021 - 2033 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Key Participant Categorization
    • 11.1.1. Market Leaders
    • 11.1.2. Emerging Players
  • 11.2. Company Market Position Analysis, 2025
  • 11.3. Estimated Company Market Share Analysis, 2025
  • 11.4. Company Categorization
  • 11.5. Company Profiles/Listing
    • 11.5.1. ZOETIS INC.
      • 11.5.1.1. Company Overview
      • 11.5.1.2. Financial performance
      • 11.5.1.3. Product benchmarking
      • 11.5.1.4. Strategic initiatives
    • 11.5.2. Boehringer Ingelheim International Gmbh
      • 11.5.2.1. Company Overview
      • 11.5.2.2. Financial performance
      • 11.5.2.3. Product benchmarking
      • 11.5.2.4. Strategic initiatives
    • 11.5.3. Merck & Co., Inc.
      • 11.5.3.1. Company Overview
      • 11.5.3.2. Financial performance
      • 11.5.3.3. Product benchmarking
      • 11.5.3.4. Strategic initiatives
    • 11.5.4. Elanco
      • 11.5.4.1. Company Overview
      • 11.5.4.2. Financial performance
      • 11.5.4.3. Product benchmarking
      • 11.5.4.4. Strategic initiatives
    • 11.5.5. Dechra
      • 11.5.5.1. Company Overview
      • 11.5.5.2. Financial performance
      • 11.5.5.3. Product benchmarking
      • 11.5.5.4. Strategic initiatives
    • 11.5.6. Ceva Sante Animale
      • 11.5.6.1. Company Overview
      • 11.5.6.2. Financial performance
      • 11.5.6.3. Product benchmarking
      • 11.5.6.4. Strategic initiatives
    • 11.5.7. Phibro Animal Health Corporation
      • 11.5.7.1. Company Overview
      • 11.5.7.2. Financial performance
      • 11.5.7.3. Product benchmarking
      • 11.5.7.4. Strategic initiatives
    • 11.5.8. Virbac
      • 11.5.8.1. Company Overview
      • 11.5.8.2. Financial performance
      • 11.5.8.3. Product benchmarking
      • 11.5.8.4. Strategic initiatives
    • 11.5.9. Bimeda Corporate
      • 11.5.9.1. Company Overview
      • 11.5.9.2. Financial performance
      • 11.5.9.3. Product benchmarking
      • 11.5.9.4. Strategic initiatives
    • 11.5.10. Biogenesis Bago
      • 11.5.10.1. Company Overview
      • 11.5.10.2. Financial performance
      • 11.5.10.3. Product benchmarking
      • 11.5.10.4. Strategic initiatives
    • 11.5.11. Vetoquinol
      • 11.5.11.1. Company Overview
      • 11.5.11.2. Financial performance
      • 11.5.11.3. Product benchmarking
      • 11.5.11.4. Strategic initiatives
    • 11.5.12. Norbrook Laboratories
      • 11.5.12.1. Company Overview
      • 11.5.12.2. Financial performance
      • 11.5.12.3. Product benchmarking
      • 11.5.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 5 Global Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 6 Global Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 7 Global Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 8 Global Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 9 Global Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 10 Global Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 11 GlobalVeterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 12 North America Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 13 North America Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 14 North America Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 15 North America Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 16 North America Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 17 North America Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 18 North America Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 19 North America Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 20 U.S. Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 21 U.S. Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 22 U.S. Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 23 U.S. Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 24 U.S. Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 25 U.S. Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 26 U.S. Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 27 U.S. Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 28 Canada Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 29 Canada Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 30 Canada Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 31 Canada Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 32 Canada Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 33 Canada Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 34 Canada Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 35 Canada Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 36 Mexico Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 37 Mexico Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 38 Mexico Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 39 Mexico Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 40 Mexico Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 41 Mexico Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 42 Mexico Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 43 Mexico Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 44 Europe Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 45 Europe Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 46 Europe Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 47 Europe Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 48 Europe Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 49 Europe Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 50 Europe Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 51 Europe Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 52 UK Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 53 UK Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 54 UK Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 55 UK Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 56 UK Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 57 UK Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 58 UK Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 59 UK Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 60 Germany Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 61 Germany Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 62 Germany Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 63 Germany Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Germany Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 65 Germany Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 66 Germany Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 67 Germany Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 68 France Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 69 France Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 70 France Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 71 France Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 72 France Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 73 France Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 74 France Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 75 France Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 76 Italy Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 77 Italy Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 78 Italy Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 79 Italy Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 80 Italy Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 81 Italy Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 82 Italy Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 83 Italy Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 84 Spain Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 85 Spain Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 86 Spain Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 87 Spain Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 88 Spain Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 89 Spain Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 90 Spain Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 91 Spain Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 92 Denmark Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 93 Denmark Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 94 Denmark Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 95 Denmark Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 96 Denmark Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 97 Denmark Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 98 Denmark Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 99 Denmark Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 100 Sweden Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 101 Sweden Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 102 Sweden Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 103 Sweden Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 104 Sweden Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 105 Sweden Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 106 Sweden Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 107 Sweden Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 108 Norway Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 109 Norway Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 110 Norway Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 111 Norway Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 112 Norway Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 113 Norway Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 114 Norway Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 115 Norway Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 116 Asia Pacific Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 117 Asia Pacific Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 118 Asia Pacific Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 119 Asia Pacific Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 120 Asia Pacific Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 121 Asia Pacific Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 122 Asia Pacific Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 123 Asia Pacific Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 124 Japan Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 125 Japan Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 126 Japan Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 127 Japan Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 128 Japan Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 129 Japan Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 130 Japan Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 131 Japan Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 132 China Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 133 China Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 134 China Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 135 China Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 136 China Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 137 China Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 138 China Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 139 China Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 140 India Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 141 India Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 142 India Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 143 India Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 144 India Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 145 India Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 146 India Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 147 India Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 148 Australia Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 149 Australia Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 150 Australia Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 151 Australia Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 152 Australia Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 153 Australia Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 154 Australia Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 155 Australia Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 156 South Korea Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 157 South Korea Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 158 South Korea Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 159 South Korea Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 160 South Korea Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 161 South Korea Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 162 South Korea Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 163 South Korea Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 164 Thailand Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 165 Thailand Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 166 Thailand Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 167 Thailand Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 168 Thailand Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 169 Thailand Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 170 Thailand Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 171 Thailand Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 172 Latin America Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 173 Latin America Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 174 Latin America Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 175 Latin America Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 176 Latin America Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 177 Latin America Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 178 Latin America Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 179 Latin America Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 180 Brazil Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 181 Brazil Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 182 Brazil Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 183 Brazil Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 184 Brazil Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 185 Brazil Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 186 Brazil Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 187 Brazil Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 188 Argentina Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 189 Argentina Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 190 Argentina Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 191 Argentina Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 192 Argentina Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 193 Argentina Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 194 Argentina Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 195 Argentina Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 196 Middle East and Africa Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 197 Middle East and Africa Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 198 Middle East and Africa Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 199 Middle East and Africa Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 200 Middle East and Africa Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 201 Middle East and Africa Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 202 Middle East and Africa Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 203 Middle East and Africa Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 204 South Africa Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 205 South Africa Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 206 South Africa Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 207 South Africa Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 208 South Africa Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 209 South Africa Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 210 South Africa Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 211 South Africa Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 212 Saudi Arabia Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 213 Saudi Arabia Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 214 Saudi Arabia Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 215 Saudi Arabia Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 216 Saudi Arabia Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 217 Saudi Arabia Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 218 Saudi Arabia Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 219 Saudi Arabia Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 220 UAE Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 221 UAE Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 222 UAE Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 223 UAE Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 224 UAE Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 225 UAE Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 226 UAE Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 227 UAE Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 228 Kuwait Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 229 Kuwait Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 230 Kuwait Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 231 Kuwait Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 232 Kuwait Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 233 Kuwait Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 234 Kuwait Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 235 Kuwait Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 236 Oman Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 237 Oman Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 238 Oman Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 239 Oman Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 240 Oman Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 241 Oman Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 242 Oman Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 243 Oman Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)
  • Table 244 Qatar Veterinary Pharmaceuticals Market, by Animal, 2021 - 2033 (USD Million)
  • Table 245 Qatar Veterinary Pharmaceuticals Market, by Production Animals, 2021 - 2033 (USD Million)
  • Table 246 Qatar Veterinary Pharmaceuticals Market, by Companion Animals, 2021 - 2033 (USD Million)
  • Table 247 Qatar Veterinary Pharmaceuticals Market, by Product, 2021 - 2033 (USD Million)
  • Table 248 Qatar Veterinary Pharmaceuticals Market, by Drug Type, 2021 - 2033 (USD Million)
  • Table 249 Qatar Veterinary Pharmaceuticals Market, by Type, 2021 - 2033 (USD Million)
  • Table 250 Qatar Veterinary Pharmaceuticals Market, by Route of Administration, 2021 - 2033 (USD Million)
  • Table 251 Qatar Veterinary Pharmaceuticals Market, by Sales Channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Million)
  • Fig. 15 Ancillary market outlook, 2025 (USD Million)
  • Fig. 16 Veterinary Pharmaceuticals Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Veterinary Pharmaceuticals Market: Animal outlook and key takeaways
  • Fig. 20 Veterinary Pharmaceuticals Market: Animal movement analysis
  • Fig. 21 Production Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Poultry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Swine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Bovine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Ovine & Caprine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Companion Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Canine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Feline Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Equine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Veterinary Pharmaceuticals Market: Product outlook and key takeaways
  • Fig. 33 Veterinary Pharmaceuticals Market: Product movement analysis
  • Fig. 34 Parasiticides Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Anti-infectives Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Anti-inflammatory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Analgesics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Other Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Veterinary Pharmaceuticals Market: Drug Type outlook and key takeaways
  • Fig. 40 Veterinary Pharmaceuticals Market: Drug Type movement analysis
  • Fig. 41 Branded Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Generics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Veterinary Pharmaceuticals Market: Type outlook and key takeaways
  • Fig. 44 Veterinary Pharmaceuticals Market: Type movement analysis
  • Fig. 45 Prescription Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 OTC Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Veterinary Pharmaceuticals Market: Route of Administration outlook and key takeaways
  • Fig. 48 Veterinary Pharmaceuticals Market: Route of Administration movement analysis
  • Fig. 49 Oral Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Topical Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Other Routes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Veterinary Pharmaceuticals Market: Sales Channel outlook and key takeaways
  • Fig. 54 Veterinary Pharmaceuticals Market: Sales Channel movement analysis
  • Fig. 55 Institutional Sales Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Veterinary Pharmacies & Retail Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 E-commerce Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Other Channels Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Regional Marketplace: Key Takeaways
  • Fig. 60 North America Veterinary Pharmaceuticals Market Estimates and Forecasts, 2018-2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 U.S. Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Canada Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Mexico Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Europe Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 UK Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Germany Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 France Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Italy Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Spain Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Denmark Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Sweden Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Norway Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Asia Pacific Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Japan Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 China Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 India Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Australia Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Thailand Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Korea Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 97 Latin America Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Brazil Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Argentina Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 102 MEA Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 103 Key country dynamics
  • Fig. 104 South Africa Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 UAE Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Saudi Arabia Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 Kuwait Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Oman Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 Qatar Veterinary Pharmaceuticals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Participant Categorization
  • Fig. 117 Company Market Position Analysis
  • Fig. 118 Strategic Framework